The Effects of Aging on Skeletal Muscle ATP Production by Abboudi, Chaya
The Science Journal of the Lander College of Arts and Sciences 
Volume 12 
Number 2 Spring 2019 Article 10 
2019 
The Effects of Aging on Skeletal Muscle ATP Production 
Chaya Abboudi 
Touro College 
Follow this and additional works at: https://touroscholar.touro.edu/sjlcas 
 Part of the Biology Commons, and the Pharmacology, Toxicology and Environmental Health 
Commons 
Recommended Citation 
Abboudi, C. (2019). The Effects of Aging on Skeletal Muscle ATP Production. The Science Journal of the 
Lander College of Arts and Sciences, 12 (2). Retrieved from 
This Article is brought to you for free and open access by the Lander College of Arts and Sciences at Touro Scholar. 
It has been accepted for inclusion in The Science Journal of the Lander College of Arts and Sciences by an 




The study of the aging process and its prevention is an incredibly popular field; the natural course of the human body is to age 
and theories abound on how to avoid it . Age affects every system and pathway of the body and alters many of the bodily func-
tions . This paper, using articles from Touro’s library database examines the different areas in which aging negatively affects ATP 
production . The multifaceted process associated with the production of ATP in the human body was analyzed . Several features such 
as the mitochondria, physical activity, and hormones are linked to ATP production and the relationship was further explored . The 
findings reveal that a dysfunction or lack of these factors, a feature of aging, is the initiator of the decrease in ATP production that 
is attributed to the natural aging process . Together, a lack of mitochondrial function, physical inactivity, reduced growth hormone 
levels, and increased insulin sensitivity levels contribute to the decline in ATP production that is concomitant with the progression 
of age . The diminishing presence of ATP then stimulates further dysfunction or lack of these elements, which in turn drives the 
aging process even further .
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Introduction
Aging is a phenomenon that all creatures go through. It is be-
lieved to be a degenerative process caused by accumulated 
damage that leads to cellular dysfunction, tissue failure and 
death. The physiological changes which lead to senescence in 
humans may involve spine curving (kyphosis), reduced fertility, 
loss of hearing and eyesight, frailty, cognitive decline and many 
other symptoms (Trifunovic et. al., 2004). All these changes in 
the body are triggered by a variety of molecular and biochemi-
cal modifications. One of the major pathways that is altered as 
people age is the cellular respiration pathway which produces 
ATP, the body’s main source of energy.
Methods
The research discussed in this paper was collected from various 
different databases. The majority of the articles were compiled 
from databases such as PubMed and ProQuest, with access to 
restricted articles gained by using Touro’s library system. Some 
articles were also found through google scholar.
An Overview of Cellular Respiration
Cellular respiration is a set of metabolic reactions to convert 
biochemical energy from nutrients into adenosine triphosphate 
(ATP). ATP is the primary energy carrier in living organisms. 
When the cell requires energy, it breaks down ATP through 
hydrolysis; a high energy bond is broken where a phosphoryl 
group is removed and energy is released. In humans, aerobic 
cell respiration has three parts. Glycolysis is the breakdown of 
glucose into two pyruvate molecules where two molecules of 
ATP and two molecules of NADH are produced without ne-
cessitating oxygen. The next step is known as the Krebs cycle, 
the citric acid cycle or the tricarboxylic acid cycle. The carbons 
in the pyruvate molecules are pulled apart and the energy 
stored in those covalent bonds is released. This step produces 
two molecules of ATP, six NADH molecules and two FADH2 
molecules. The third and final step is the electron transport 
chain and oxidative phosphorylation. Here, oxygen is required 
and about thirty-four molecules of ATP are produced. The 
second two steps of cellular respiration, which are the main 
energy-producing steps, occur in the mitochondria, unlike gly-
colysis which takes place in the cytoplasm (Fernie et. al., 2004).
Oxidative phosphorylation is the metabolic pathway in which 
cells use enzymes to oxidize nutrients. Electrons are fed from 
reduced substrates such as NADH, FADH2, fatty acids or glyc-
erol phosphates into the electron transport chain located in 
the inner membrane of the mitochondria. Big membrane-bound 
enzymes such as the dehydrogenases of b-oxidation, glycerol 
phosphate dehydrogenase, NADH-Q oxidoreductase (Complex 
I) or succinate-Q oxidoreductase (Complex II) pass electrons 
down the gradient of redox potential to ubiquinone (Q) which 
is a mobile lipid-soluble carrier. The electrons then get passed 
down from ubiquinone to the final acceptor, oxygen, through 
Q-cytochrome c oxidoreductase (Complex III), cytochrome c 
(a second, water-soluble, mobile carrier) and cytochrome c oxi-
dase (Complex IV). As the electrons move from less electroneg-
ative to more electronegative molecules, they lose energy, and 
with that energy, Complex I, Complex III and Complex IV pump 
protons against their electrochemical gradient from the matrix 
to the intermembrane space. A protonmotive force, consisting 
mostly an electrical gradient (membrane potential) and a small 
chemical gradient, (pH difference) is set up due to the pumping 
of protons. This protonmotive force then pushes the protons 
back into the matrix through the ion channel ATP synthase 
which harvests the energy and creates ATP (Saraste, 1999).
Being that the main organelle involved in cellular respiration 
is the mitochondrion, dysfunction of this organelle must be the 
driving force behind the lack of energy in cells, resulting in cell 
death. This implies that dysfunctional mitochondria must be of 
central focus in aging. The decline of mitochondrial function with 
age has been recognized for some time and has been linked to 
a decreased number of mtDNA and mitochondrial protein lev-
els in human heart, brain and skeletal muscle cells. Additionally, 
aged muscle suffers from functionally impaired respiratory 
chain units, inhibiting respiration associated with ATP produc-
tion (Zapico et. al., 2016). The mitochondria in elderly tissue has 
often been found to be larger, fewer in number and contain ab-
normal cristae, vacuoles and paracrystalline inclusions (Hutter 
et. al., 2007). When the quadriceps of thirty participants whose 
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ages ranged from 78.5 ± 5. years were examined, an inverse rela-
tionship between the fatiguability level and the level of oxidative 
phosphorylation (ATPmax) was reported. Higher fatigue levels, 
a condition which is extremely common with advancing age, 
is caused by a decrease in mitochondrion capacity for oxida-
tive phosphorylation (Santanasto et. al., 2014). In another study, 
permeabilized muscle fibers from the vastus lateralis were stud-
ied from twenty-four young (approximately thirty years) and 
thirty-one older (approximately sixty-five years) subjects. This 
study was to determine if there was a change in mitochondrial 
respiratory capacity and coupled respiration (respiration linked 
to ATP production) with age and the results showed a decline 
in both (Porter et. al., 2015). There are many possible reasons 
for this decline in mitochondrial function but the most accepted 
theory seems to be the Free Radical Theory of Aging.
Mitochondrial Free Radical Theory of Aging
Oxidative damage is a main cause of cell degeneration. Since the 
mitochondria are involved in many redox reactions, they are 
extremely prone to oxidative stress. The source of oxidative 
damage is the free radicals known as oxidants or reactive oxy-
gen species (ROS) which are a byproduct of redox-reaction and 
therefore produced during aerobic respiration (Harman, 1956). 
Normally, a small fraction of the oxygen consumed by the mito-
chondria is converted into reactive oxygen species, but defects 
in the respiratory chain lead to greater production of these free 
radicals (Lee et. al., 2000).   Superoxide Dismutase (SOD), an 
enzyme whose activity is present in subcellular compartments 
where there is O−2⋅ formation, was used as a tool to reveal 
that the mitochondria are a principle source of endogenous ox-
idants. Some of the SOD activity was recognized in the matrix 
space and the other half in the inner and outer membranes of 
the mitochondria (Imray, Fridovich, 1991). 
Ground state diatomic oxygen is not too reactive itself because 
its two unpaired electrons are located in different molecular or-
bitals and possess parallel spins. As a result, in order for O2 to 
simultaneously accept two electrons, they must both possess an-
tiparallel spins relative to the unpaired electrons. Consequentially, 
O2 preferentially accepts electrons one at a time from other 
radicals (such as transition metals in certain valences). In living 
organisms, therefore, oxygen must participate in coordinated, 
serial, enzyme-catalyzed one-electron reductions in order to be 
reduced by two or four electrons. The enzymes that carry out 
these reactions generally possess active-site radical species such 
as iron. This method of O2  reduction generates O−2⋅ and hy-
drogen peroxide (H2O2). When in the company of free transition 
metals (specifically iron and copper), O−2⋅ and H2O2 together 
produce the hydroxyl radical (⋅OH) (Wood, 1988). This extreme-
ly reactive radical is presumed to be the species responsible for 
initiating the oxidative destruction of biomolecules (Harman, 
1956). When mitochondrial DNA of cells which can no longer 
reproduce undergoes oxidative damage it results in mutations 
and blocks in replication, leading to mitochondrial dysfunction 
and ultimately a decline in ATP production.
 One study demonstrated that older people have significantly 
higher oxidative damage to DNA and that mtDNA abundance 
decreases with age. The decrease in mtDNA is attributed to the 
lessened content of mRNA transcripts that encode mitochon-
drial protein. The skeletal muscle of the elderly population was 
found to contain a reduced amount of mitochondrial proteins 
and oxidative enzymes (enzymes that catalyze redox reactions 
and increase the rate at which ATP is produced aerobically). 
Accumulated oxidative damage can be the reason for lessened 
mtDNA content in aging muscle. DNA oxidation, the process of 
oxidative damage on Deoxyribonucleic Acid, was observed to 
increases with age. Also, there is a higher activity of antioxidant 
enzymes in older rat muscles, indicating that the ROS produc-
tion rate increases with age; the ROS production rate surpasses 
the activity of the antioxidants defense enzymes (Short et. al., 
2005). The decline in mtDNA content is a contributing factor 
to dysfunctional mitochondria because it means that there is a 
lack of template availability for transcription and translation of 
crucial mitochondrial proteins. The reduction of mitochondrial 
protein synthesis and oxidative enzyme activity helps explain 
the reduced ability of mitochondria to perform oxidative phos-
phorylation in older muscle. This study concluded that there is 
a decline in mitochondrial ATP production rate (MAPR), and its 
point of validity comes from the fact that the subjects were well 
suited for the study. They had a large group of one hundred and 
forty-six healthy men and women ranging in age from nineteen 
to eighty-nine. Their physical activity was taken into account and 
they were subjects who were not regularly doing exercise (less 
than thirty minutes less than two days a week). In response to 
the studies which show that physical activity improves muscle 
mitochondrial biogenesis, the physical activity of the subjects 
was taken into account. Only men and women who were not 
regularly exercising, with activity totaling less than thirty min-
utes for less than two days a week, were chosen.  Also, the 
participants were kept on a standard diet for three days be-
fore muscle biopsies from their vastus lateralis were taken for 
study. A key finding of this study was the decline in the MAPR 
of skeletal muscle with age due to a combination of reduced 
mitochondrial content and a functional alteration in the existing 
mitochondrial population (Short et. al., 2005).
In response to the production of ROS, uncoupling agents such 
as dinitrophenol (DNP) are produced. These agents are lipid-sol-
uble weak acids that can cross the mitochondrial membrane. 
Once inside the mitochondria, these proteins eliminate the link 
between oxidation and phosphorylation. They accomplish this 
by setting up a catalytic cycle that dissipates the protonmo-
tive force, allowing the continuation of substrate oxidation all 
the while lacking the driving force for coupled ATP synthesis. 
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This is a thermogenic process and occurs in many living cells 
including skeletal muscle cells (Brand, 2000). The first known 
UCP, UCP1 is the one that controls brown fat which is one of 
the body’s ways of regulating thermogenesis. In the brown adi-
pose tissue, the proton leak through UCP1 is a mechanism that 
exploits energy generally used to create ATP to generate heat. 
This method of thermogenesis regulated by brown fat UCP1 is 
important in numerous physiological conditions such as arousal 
from hibernation and cold exposure in newborns. The question 
of the reason for this process arises. What reason is enough to 
validate a reduction in ATP level and such a high energetic price? 
To strengthen this question, it is known that thermogenesis is 
not enough of motivation because this uncoupling process is 
done by both endotherms and ectotherms. The reasoning be-
hind this seemingly troubling process is the diminution of ROS 
production, a protection against cellular degeneration (Brand, 
2000). When calculated, the respiratory capacity used for phos-
phorylation and respiratory function linked to ATP production 
in older adults was lower than in the young (Porter et. al., 2015). 
Not only do the presence of free radicals (which are a result of 
aging) lower the skeletal muscle ATP production, but the cell’s 
natural response and method to protect itself against oxidative 
damage, which involves uncoupling proteins, is also a major con-
tributing factor to the reduction of ATP production.
A more indirect but lethal effect oxidants have on the mi-
tochondria is that they disrupt the activity of the lysosomes. 
Oxidative damage is responsible for depositing lipofuscin in 
the lysosomes. Lipofuscin us the yellow pigment granules made 
up of lipid residues of lysosomal digestion, and accumulation 
of lipofuscin alters the lysosomal autophagic ability. Because 
the lysosomes take care of recycling unnecessary material and 
organelles (such as viruses or damaged particles), their failure 
results in a buildup of unwanted particles in the cell (Konig et. 
al., 2017). Decreased macroautophagic activity from lysosomal 
leakage was observed in rat cells, and is a central reason for 
the accumulation of damaged mitochondria in aged cells. This 
buildup is associated with a decrease in mitochondrial effi-
ciency and an increase in oxidant generation (Roberg, Ollinger, 
1998). The decline in autophagic activity as a common charac-
teristic of aging makes for clogged lysosomes due to lipofuscin 
and mitochondrial deterioration. This process in which mito-
chondrial ROS encourage lipofuscin generation while the ac-
cumulation of lipofuscin disturbs the mitochondrial autophagy 
is known as the “garbage catastrophe theory of aging” (Hutter 
et. al., 2007).
Therefore, oxidative destruction of molecules involved in 
aerobic respiration (such as oxidative enzymes, mitochondrial 
proteins or mtDNA) leads to defective mitochondria. The mi-
tochondria themselves are primary targets of oxidative damage 
and increase their production of ROS once destroyed. Putting 
these two processes together results in a disastrous vicious 
cycle in which the synthesis of malfunctioning electron trans-
port chain subunits results in oxidative phosphorylation impair-
ment, decreased ATP production and further ROS generation.
Physical Activity
There are many studies which say that the primary contributing 
factor to reduced mitochondrial function is the lack of physical 
activity. In one study, thirty-nine volunteers were to complete 
graded exercise tests to determine their daily physical activity, 
fitness, and  exercise efficiency. The group of volunteers included 
ten young active people about thirty years old, ten older active 
people about sixty-seven years old and nineteen older sedentary 
people. Mitochondrial energetics from biopsies of the vastus lat-
eralis were measured via magnetic resonance spectroscopy and 
respirometry. The results of this study showed a higher fitness 
level in the young active compared to the older active and older 
sedentary. The mitochondrial respiration, maximum mitochondri-
al capacity, Maximal ATP production/Oxygen consumption (P/O) 
ratio, and exercise efficiency were similar in the young active and 
older active and were significantly lower in older sedentary. This 
study concluded that constant physical activity makes for better 
mitochondrial capacity (Distefano et. al., 2018).
 Besides for physical activity having an effect on the mitochon-
drial efficiency (ATPmax/max O2 consumption), the reverse is 
also true. Lessened mitochondrial efficiency seems to have a 
negative effect on older peoples’ physical activity. A study was 
done to analyze whether or not slower walking speed in older 
adults is related to reduced mitochondrial capacity and effi-
ciency. A group of thirty-seven older people (ages ranging from 
seventy to eighty-nine) who were of normal weight (under 286 
lb for the men and under 251 lb. for the women) were chosen. 
They were able to walk unassisted and had no symptoms of 
cardiovascular or pulmonary disease. They had no pain or stiff-
ness in the legs, hips, knees, feet, or ankles when walking and no 
difficulty bending or straightening the knees. The participants 
were told to complete a 400-meter walk within 15 minutes at 
their normal walking speed. Afterward, muscle fibers biopsies 
from the vastus lateralis were taken to be observed. A key find-
ing was that muscle mitochondrial efficiency correlated with the 
participants walking speed. This study concluded that the loss of 
mitochondrial capacity and efficiency with age may be import-
ant contributors to the reduction in mobility and increase in 
disability. This is due to the relationship between mitochondrial 
capacity and walking speed (Coen et. al., 2012). 
The link between physical activity and mitochondrial ener-
getics is that aerobic exercise enhances muscle mitochondrial 
biogenesis. Resistance training in older people can increase 
the protein synthesis rate. The content and function of certain 
proteins in the muscle which are vital to its functioning, de-
pend on the protein synthesis rate (Short et. al., 2005). Exercise 
counteracts decay which happens in aging muscle by heightening 
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muscle protein turnover. Because muscle mitochondrial content 
and function is reduced with age, the resting and maximal oxy-
gen consumption also decline with advancing age (Short et. al., 
2004). The VO2max of an individual is closely associated with 
mitochondrial ATP production and so a decline in the VO2max 
with age means that it is correlated with a decline in ATP pro-
duction. In muscle samples taken from healthy individuals ranging 
from eighteen to eighty-seven years, the VO2max while cycling 
declined approximately eight percent per decade (Short et. al., 
2005). If constant physical activity throughout one’s life is what 
can keep the VO2max at a decent level, it must be that physical 
decline, a common occurrence in aging, is in part a contribution 
to the reduction of ATP production.
Sarcopenia and Physical Decline
Sarcopenia, a natural part of the aging process, is the progressive 
decline of muscle mass, strength and physical function. The loss 
rate is believed to accelerate after the age of sixty-five. The de-
terioration of muscle quantity and quality leads to a decline in 
strength and power and a slowing of movement, all features of 
sarcopenia (Baumgartner et. al., 1999). A deterioration in muscle 
mass is followed by a decline in physical activity which has been 
negatively linked to mitochondrial function.
Age-related hormonal changes seem to be a possible mech-
anism for the onset of sarcopenia. Insulin-like growth factor 
1 (IGF-1) is a protein that is encoded by the IGF-1 gene. This 
hormone plays a fundamental role in childhood growth and 
continues to have anabolic effects in adulthood. The production 
of IGF-1 is stimulated by growth hormone.  Growth hormone 
(GH) is made in the anterior pituitary gland, released into the 
blood stream, and then stimulates the liver to produce IGF-
1. IGF-1 is the stimulation for systemic body growth, and has 
proliferating effects on many cells in the body, especially skeletal 
muscle (Laron, 2001). After twenty years of age, the secretion of 
growth hormone decreases by approximately fourteen percent 
per decade. This decline is followed by a reduction in IGF-1, 
which is responsible for cell production, energy metabolism, and 
inhibition of apoptosis (Giannoulis et. al., 2008).  
 Testosterone, an anabolic steroid which increases muscle 
protein synthesis, begins to drops in male serum levels in the 
late thirties and continues to decline throughout adulthood. A 
group of older men were treated with testosterone in order 
to increase their testosterone level to that of younger men. 
The treatment attenuated one symptom of sarcopenia, the loss 
of muscle mass (Storer et. al., 2016). In females, the positive 
correlation between plasma estrogen levels and muscle mass 
suggests that reduced estrogen following menopause may result 
in reduced muscle mass as well (Van Geel et. al., 2009).
 Although there was no change in muscle mass or strength 
when healthy males were treated with GH alone, the addition 
of testosterone to the treatment resulted in a 6.8% increase in 
muscle strength. There was also an increase in lean body mass 
(LBM=total body weight minus the fat) which indicates the cor-
relation between lean body mass and strength; a change in LBM 
results in a change in strength. Along with increase in LBM came 
an increase in VO2max. (Blackman et. al., 2002). An effective 
mechanism to increase the endogenous levels of somatotropic 
hormones (such as GH and IGF-1) in the blood is training and 
exercise. A thirteen-week combined sprint and resistance train-
ing in middle-aged men improved the body composition and 
increased circulating GH. There was also an increase in IGF-1 
level following the exercise which shows that training can coun-
teract the natural decline in somatotropic hormones during 
aging (Sellami et. al., 2017). A decrease in GH and testosterone, 
vital anabolic hormones, plays a big role in the loss of muscle 
mass which is a key element in the development of sarcopenia.
Another possible cause of sarcopenia is the acceleration of 
apoptotic pathways. Apoptosis is the highly regulated and con-
trolled process of cell death in multicellular organisms. This pro-
cess can happen via the intrinsic pathway in which the cell kills 
itself because it senses cell stress, or the extrinsic pathway, where 
the cell kills itself because of signals from the other cells. Both 
pathways initiate the activity of caspases, enzymes that destroy 
proteins. Apoptosis is a homeostatic process which keeps our 
body balanced between all the new cells arising from stem cells 
and the billions of cells dying each day. This very beneficial process 
becomes a problem when it accelerates with age and results in 
the loss of muscle mass and strength. Although the mechanism for 
the acceleration of these pathways is unknown, what is known is 
that there are many contributing factors such as oxidative stress 
and impaired insulin sensitivity (Marzetti et. al., 2012).  
Insulin Resistance
A major finding in old age is insulin resistance. Insulin is a hor-
mone produced by the pancreas and regulates the amount of 
glucose in the blood. Resistance to this hormone can result in 
type 2 diabetes. Age associated decline in mitochondrial func-
tion seems to be related to insulin resistance. The MAPR was 
found to be approximately thirty percent less in patients who 
were insulin resistant compared to those who were not, and 
that was consistent with the finding of altered mitochondria 
(Petersen et. al., 2004). The altered mitochondria and reduced 
MAPR is known to be a contributing factor to insulin resistance. 
In addition to that, insulin stimulates transcription and trans-
lation of mitochondrial proteins and genes thereby increasing 
MAPR and this effect is lacking in those with type 2 diabetes. So, 
whether insulin resistance causes a decrease in mitochondrial 
function or the reverse, both possibilities are plausible for they 
seem to each have an effect on the other (Short et.al., 2005). 
In a study done to determine if insulin enhances the capacity of 
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mitochondrial ATP production in skeletal muscle, both subjects 
with and without type 2 diabetes were recruited and muscle bi-
opsies of the vastus lateralis were examined. The muscles were 
infused with a low dosage of insulin and a high dosage of insulin 
and were studied after eight hours. Mitochondrial protein com-
plexes, whose syntheses are dependent on coordinated tran-
scriptional regulation of mitochondrial and nuclear genes, must 
be available for mitochondrial ATP production to occur. In the 
subjects without diabetes, the high dose insulin infusion resulted 
in a higher mitochondrial fractional synthesis rate. Additionally, 
there was an increase in the activities of the oxidative enzymes 
citrate synthase and cytochrome-c¬-oxidase subunit IV (a part 
of complex IV). (Citrate synthase is the pace-making enzymes of 
the first step in the citric acid cycle and increased activity of the 
citric acid cycle may increase the rate of ATP production.) There 
was also an increase in the mRNA level from both mitochondri-
al (NADH dehydrogenase subunit IV) and nuclear (cytochrome 
c oxidase subunit IV) genes encoding mitochondrial proteins. 
After eight hours of high dose insulin infusion, the mitochondri-
al ATP production rate of the individuals with type 2 diabetes 
did not change. Clearly, insulin infusion increases mitochondrial 
protein synthesis and the mitochondrial capacity for oxidative 
phosphorylation in skeletal muscle (Stump et. al., 2003). Insulin 
is not only important for regulating the blood sugar level but 
it is also heavily involved in ATP production. Resistance to this 
hormone, resulting from dysfunctional mitochondria, causes a 
decrease in mitochondrial protein content thus reducing mito-
chondrial respiration and ATP production. 
Conclusion
The free radical theory of aging which gives reason for the mal-
functioning mitochondria is itself a result of dysfunctional mito-
chondria. Increased ROS production, a byproduct of mitochon-
drial decay disrupts lysosomal activity creating the additional 
accumulation of damaged mitochondria followed by an increase 
in oxidants. An additional result of oxidative damage is the de-
crease in muscle mass, muscle strength and movement. The op-
posite is also true, physical activity has been shown to increase 
muscle mass and counteract the production of free radicals 
(ROS) while physical inactivity has shown to increase ROS lev-
els, increase sarcopenia and decrease insulin sensitivity. Insulin 
resistance is another result of oxidant accumulation and phys-
ical inactivity and causes additional ROS content by disturbing 
mitochondrial protein synthesis. Essentially, all of these factors 
are negative feedback loops that influence each other. Studies 
which failed to see the correlation between these features and 
decreased ATP production with age, may be because they failed 
to look at all of these factors as a whole and recognize that 
when they all come together, create a vicious cycle. Although 
it is unclear how and where this natural process starts, once it 
does, there is no way to end it. The decrease in ATP production 
in skeletal muscle is an ordinary part of the aging process which 
results in driving the aging process even further.
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